EXPLORER PET/CT: Evaluation of Healthy Individuals From Racial/Ethnic Minority Populations

Completed · Not applicable

Conditions studied: Healthy Volunteers From Racial/Ethnic Minority Populations

In brief

The objective of this pilot study is to collect preliminary data using total body scans on a new, first of its kind, FDA 510k-cleared positron emission tomography/computed tomography (PET/CT) scanner, called EXPLORER. The study will aim to recruit healthy individuals from racial/ethnic minority populations.

Key facts

Study ID

NCT04812080

Run by

University of California, Davis

People needed

20

Starts

2021-08-18

Expected to finish

2021-11-08

Last updated by the study team

2026-03-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Men and women, 18 years of age or older
• Member of a Federally recognized racial/ethnic minority population, e.g., African American or Black; Hispanic or Latino; Asian American; Native Hawaiian or Other Pacific Islander; Native American or Alaska Native
• Willing and able to fast for at least 6 hours before and for the duration of the scan
• Willing to provide urine samples throughout scan visit
• Willing to provide blood samples for ancestry analysis
• Willing and able to lay motionless in a supine position for up to 60 minutes and for up to 20 minutes at two separate timepoints
• Willing and able to give informed consent, personal contact information (phone number, email and postal address), insurance information, and primary care physician contact

You may not qualify if…

• No Primary Care Physician
• No health insurance
• Body weight more than 240 kg (529 pounds)
• Any known concomitant acute infection (including upper respiratory infection, genitourinary infections, etc.)
• History of metastatic or newly (last 5 years) diagnosed locally invasive cancer
• Chemotherapy in the last 5 years
• Radiation therapy in the last 3 years
• Major surgery within the last 6 months
• Pregnancy or breast-feeding
• Diabetes
• Fasting blood glucose level > 200 mg/dL before administration of fluorodeoxyglucose (FDG)
• Prisoners
• Self-reported history of dysphoria or anxiety in closed spaces

Where it is running

• University of California, Davis — Sacramento, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.